Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
European Neuropsychopharmacology(1)
Human Vaccines and Immunotherapeutics(1)
Infectious Diseases in Obstetrics and Gynecology(1)
Vaccines(1)
A Need for Standardization of the Diagnosis and Treatment of Pelvic Inflammatory Disease: Pilot Study in an Outpatient Clinic in Quito, Ecuador
ArticleAbstract: Background. Pelvic inflammatory disease (PID) diagnosis is often challenging as well as its treatmenPalabras claves:Autores:Andrés Caicedo, Francisco Cueva, Paula HidalgoFuentes:scopusFactors Associated with Vaccination Intention against the COVID-19 Pandemic: A Global Population-Based Study
ArticleAbstract: Several vaccines have been developed for COVID-19 since the pandemic began. This study aimed to evalPalabras claves:Chronic conditions, covid-19, Mental Health, vaccination intention, VaccineAutores:Andrés Caicedo, Chan S.C., Chen P., Huang J., Huang J.L.W., Jiang J.Y., Ko S., Medina-Arellano M.d.J., Murphy J.K., Palaganas E., Paredes M.B.A., Somrongthong R., Viwattanakulvanid P., Wang H.H.X., Withers M., Wong M.C.S., Xu W., Xue H., Yuan J., Zhang L., Zheng Z.J.Fuentes:googlescopusInequities, vulnerabilities and ethics in the time of COVID-19: diverse perspectives from the APRU Global Health Program
OtherAbstract: The coronavirus disease 2019 (COVID-19) pandemic has raised a myriad of ethical concerns, in clinicaPalabras claves:Autores:Andrés CaicedoFuentes:googlePsychiatric disorders in Post-acute COVID-syndrome (PDPACS): Recommendations for health care professionals
OtherAbstract:Palabras claves:Autores:Andrea Falconi Paez, Andrés Caicedo, Bryan Nicolalde, Camila Esquetini-Vernon, Fusaro S., Gabriel Capa, Kevin Zambrano, Ocampo J., Yana Lara-TaranchenkoFuentes:googlescopusPublic health impact and economic benefits of quadrivalent influenza vaccine in Latin America
ArticleAbstract: Annual trivalent influenza vaccines (TIV) containing 2 A strains and one B lineage have been recommePalabras claves:benefit, Brazil, COLOMBIA, Cost, influenza, Latin America, Panamá, PUBLIC HEALTH, quadrivalent, VaccineAutores:Alfonso P., Andrés Caicedo, Bricks L., Clay E., Franco D., Garcia Diaz L., Isaza de Molto Y., Jamotte A., Lopez J.G., Macabeo B., Marrugo R., Moreno Arévalo B., Romero Prada M.Fuentes:scopus